Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Migraine Disorders: HELP
Michel Lantéri-Minet
Based on 35 articles published since 2008
||||
Expertise Level
The expertise of Michel Lantéri-Minet ranks in the
  • Top 0.25%
  • ... of 22,748 published authors worldwide on Migraine Disorders
  • ... from 2008 through 2019
  • ... based on contributions to 35 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Lantéri-Minet, M   ·   Lanteri-Minet, Michel   ·   Lanteri-Minet, M   ·   Lantéri-Minet, Michel
Work Locations
Details
Most likely:    Miscellaneous institutions in Nice      
2018
  • 1 Mayo Clinic, Scottsdale, AZ, USA. · 2 Danish Headache Center, Rigshospitalet Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · 3 Department of Neurology, Vanderbilt University School of Medicine and Nashville Neuroscience Group, Nashville, TN, USA. · 4 California Medical Clinic for Headache, Santa Monica, CA, USA. · 5 Pain Department and FHU InovPain, CHU Nice, France. · 6 Neurological Research Department, First Sechenov Moscow State Medical University and Research Center for Neuropsychiatry, Moscow, Russia. · 7 36026 Amgen Ltd , Cambridge, UK. · 8 7129 Amgen Inc. , Thousand Oaks, CA, USA. · Pubmed 29471679
  • European Headache Federation, Rome, Italy. · Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy. · Department of Neurology, Mayo Clinic, 5777 East Mayo Boulevard, Phoenix, AZ, 85054, USA. · Département d'Evaluation et Traitement de la Douleur CHU Nice, FHU InovPain, Université Côte Azur, Nice, France. · GfK EMER, Madrid, Spain. · IPSOS Switzerland (formerly GfK Health), Basel, Switzerland. · Department of Neurology and Headache Center, University of Duisburg-Essen, Duisburg, Germany. · European Migraine and Headache Alliance (EMHA), Brussels, Belgium. · Migraine Association of Ireland (MAI), Dublin, Ireland. · Danish Headache Center, Rigshospitalet Glostrup, Copenhagen, Denmark. · Migraine Action, Leicester, UK. · Novartis Pharma AG, Basel, Switzerland. · European Federation of Neurological Associations, Brussels, Belgium. · Migraine Again, Irvine, USA. · Pubmed 30482181
2016
  • Centre d'évaluation et de traitement de la douleur, Hôpital Timone, Pôle Neurosciences Cliniques, Hôpital de la Timone, Marseille, France. · INSERM/UdA, U1107, Neuro-Dol, Clermont-Ferrand, France. · Aix Marseille Université, CNRS 7289-Institut de Neurosciences Timone, Centre d'Evaluation et d'Information sur la Pharmacodépendance & Addictovigilance PACA-Corse, Service de Pharmacologie Médicale et Clinique, AP-HM, Marseille, France. · Direction Régionale du Service Médical de l'Assurance Maladie Provence-Alpes-Côte d'Azur et Corse (CNAMTS), Marseille, France. · Département d'Evaluation et Traitement de la Douleur, Pôle Neurosciences Cliniques du CHU de Nice, Hôpital Cimiez, Nice, France. · Pubmed 26995706
  • Headache Medical Center, Linz, Austria. · Department of Neurogeriatric Medicine and Remobilisation, Hospital of the Sisters of Charity, Linz, Austria. · Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway. · Norwegian Advisory Unit on Headache, St Olavs University Hospital, Trondheim, Norway. · Headache Science Centre, C Mondino National Neurological Institute, Pavia, Italy. · Department of Brain and Behavioural Sciences, University of Pavia, Pavia, Italy. · Department of Neurology, University of Duisberg-Essen, Essen, Germany. · Department of Neurology, Evangelical Hospital Unna, Unna, Germany. · Department of Neurology, Hospital Clinico Universitario, University of Valencia, Valencia, Spain. · Departement d'Evaluation et Traitement de la Douleur, Centre Hospitalo-Universitaire de Nice, Nice, France. · INSERM/UdA, U1107, Neuro-Dol, Clermont-Ferrand, France. · Lithuanian University of Health Sciences, Kaunas, Lithuania. · Asociacion Española de Pacientes con Cefalea (AEPAC), Valencia, Spain. · Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland. · Department of Population Health, Luxembourg Institute of Health, Strassen, Luxembourg. · Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway. · Division of Brain Sciences, Imperial College London, London, UK. · Pubmed 26879832
2014
  • Departement d'Evaluation et de Traitement de la Douleur, Hopital Cimiez, 4, avenue Reine-Victoria, 06000 Nice, France. · Pubmed 24400971
  • Département d'Evaluation et Traitement de la Douleur, Pôle Neurosciences Cliniques CHU de Nice, Hôpital de Cimiez, 4 avenue Reine Victoria, 06000, Nice, France, · Pubmed 24338699
2013
  • Département évaluation et traitement de la douleur, pôle neurosciences cliniques, hôpital de Cimiez, CHU de Nice, 4, avenue Reine-Victoria, 06001 Nice, France. · Pubmed 23602496
  • Département d'évaluation et de traitement de la douleur, hôpital Cimiez, 4, avenue Reine-Victoria, 06000 Nice, France. · Pubmed 23246266
2012
2011
  • Département d’Evaluation et Traitement de la Douleur Médecine Palliative, Pôle Neurosciences Cliniques, CHU de Nice-Hôpital Pasteur, 30 Avenue de la Voie Romaine, Nice cedex 1, France. · Pubmed 21464078
2010
  • Département d'Evaluation et Traitement de la Douleur, Pôle Neurosciences, Cliniques du Centre Hospitalo-Universitaire de Nice, Hôpital Pasteur, Nice, France. · Pubmed 20584227
  • Département d'Evaluation et Traitement de la Douleur, Pôle Neurosciences Cliniques, Hôpital Pasteur, 30 avenue de la Voie Romaine, 06002 Nice cedex, France. · Pubmed 20001575
2008
  • Département d'Evaluation et Traitement de la Douleur, Pôle Neurosciences Cliniques, Hôpital Pasteur, Nice, France. · Pubmed 18715326
  • Département d'évaluation et traitement de la douleur, pôle des neurosciences cliniques, CHU de Nice, hôpital Pasteur, 06002 Nice. · Pubmed 18437947
Probable:    INSERM France      
2016
  • Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, ON, Canada. · Redwood Outcomes, 302-1505 2nd Ave. West, Vancouver, BC, Canada. · Department of Medicine, St. Vincent's Hospital, The University of Melbourne, Melbourne, Australia. · Redwood Outcomes, 302-1505 2nd Ave. West, Vancouver, BC, Canada. · Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. · School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. · Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, ON, Canada. · Pfizer Ltd, New York, NY, USA. · Pain Department, CHU Nice, France - FHU InovPain, Université Nice Côte d'Azur, Nice, France. · INSERM U1107, Neuo-Dol, Trigeminal Pain and Migraine Université Auvergne, Clermont-Ferrand, France. · Geisel School of Medicine at Dartmouth, Hanover, NH, USA. · Pubmed 27882516
  • Pôle neurosciences cliniques, département d'évaluation et traitement de la douleur, hôpital de Cimiez, CHU de Nice, 4, avenue Reine-Victoria, 06300 Nice, France; Inserm/UdA, U1107, neuro-dol, UFR odontologie, 2, rue de Braga, 63000 Clermont-Ferrand, France. Electronic address: · Cabinet de neuropyschiatrie, 12, rue Louis-Braille, 31250 Ramonville-Saint-Agne, France. · Pubmed 26708620
  • Centre d'évaluation et de traitement de la douleur, Hôpital Timone, Pôle Neurosciences Cliniques, Hôpital de la Timone, Marseille, France. · INSERM/UdA, U1107, Neuro-Dol, Clermont-Ferrand, France. · Aix Marseille Université, CNRS 7289-Institut de Neurosciences Timone, Centre d'Evaluation et d'Information sur la Pharmacodépendance & Addictovigilance PACA-Corse, Service de Pharmacologie Médicale et Clinique, AP-HM, Marseille, France. · Direction Régionale du Service Médical de l'Assurance Maladie Provence-Alpes-Côte d'Azur et Corse (CNAMTS), Marseille, France. · Département d'Evaluation et Traitement de la Douleur, Pôle Neurosciences Cliniques du CHU de Nice, Hôpital Cimiez, Nice, France. · Pubmed 26995706
  • Headache Medical Center, Linz, Austria. · Department of Neurogeriatric Medicine and Remobilisation, Hospital of the Sisters of Charity, Linz, Austria. · Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway. · Norwegian Advisory Unit on Headache, St Olavs University Hospital, Trondheim, Norway. · Headache Science Centre, C Mondino National Neurological Institute, Pavia, Italy. · Department of Brain and Behavioural Sciences, University of Pavia, Pavia, Italy. · Department of Neurology, University of Duisberg-Essen, Essen, Germany. · Department of Neurology, Evangelical Hospital Unna, Unna, Germany. · Department of Neurology, Hospital Clinico Universitario, University of Valencia, Valencia, Spain. · Departement d'Evaluation et Traitement de la Douleur, Centre Hospitalo-Universitaire de Nice, Nice, France. · INSERM/UdA, U1107, Neuro-Dol, Clermont-Ferrand, France. · Lithuanian University of Health Sciences, Kaunas, Lithuania. · Asociacion Española de Pacientes con Cefalea (AEPAC), Valencia, Spain. · Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland. · Department of Population Health, Luxembourg Institute of Health, Strassen, Luxembourg. · Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway. · Division of Brain Sciences, Imperial College London, London, UK. · Pubmed 26879832
2015
  • Aix Marseille Université, CNRS 7289 - Institut de Neurosciences Timone, Centre d'Evaluation et d'Information sur la Pharmacodépendance & Addictovigilance PACA-Corse, Service de Pharmacologie Clinique et Pharmacovigilance, France. · Centre d'évaluation et de traitement de la douleur, hôpital Timone, Pôle Neurosciences Cliniques, Hôpital de la Timone, France INSERM/UdA, France. · Direction Régionale du Service Médical de l'Assurance Maladie Provence-Alpes-Côte d'Azur et Corse (CNAMTS), France. · INSERM/UdA, France Département d'Evaluation et traitement de la Douleur, Pôle Neurosciences Cliniques du CHU de Nice, Hôpital Cimiez, France. · Aix Marseille Université, CNRS 7289 - Institut de Neurosciences Timone, Centre d'Evaluation et d'Information sur la Pharmacodépendance & Addictovigilance PACA-Corse, Service de Pharmacologie Clinique et Pharmacovigilance, France · Pubmed 25667299
2014
  • Département d'évaluation et de traitement de la douleur, hôpital Cimiez, bâtiment Mossa, 4, avenue Reine-Victoria, 06000 Nice, France; Inserm/UdA, U1107, Neuro-Dol Clermont-Ferrand, faculté de médecine, BP 38, 28, place Henri-Dunant, 63001 Clermont-Ferrand, France. · Service de neurologie, hôpital de la Croix-Rousse, hospices Civils de Lyon, 103, grande rue de la Croix-Rousse, 69004 Lyon, France. · Cabinet privé, 73, boulevard de Cimiez, 06000 Nice, France. · Cabinet privé, 3, rue Henri Matisse, 91100 Corbeil Essonnes, France. · Cabinet privé, 90, rue Jean-Pierre-Timbaud, 75011 Paris, France. · Cabinet privé, 3, avenue Henri-Delecaux, 59130 Lambersart, France. · Unité de traitement de la douleur chronique, CHU de Bordeaux, 1, place Amélie-Raba-Léon, 33076 Bordeaux, France. · Service de neurologie, hôpital Rangueil, 1, avenue du Pr-Jean-Poulhès, TSA 50032, 31059 Toulouse cedex, France. · Centre d'évaluation et de traitement de la douleur, CHRU, avenue Georges-Clemenceau, 14033 Caen cedex 9, France. · Centre d'évaluation et de traitement de la douleur, hôpital Bellevue, CHU, pavillon 50, 42055 Saint-Étienne, France. · Cabinet privé, 13, place d'Aligre, 75012 Paris, France. · Cabinet privé, 1, chemin du Penthod, 69300 Caluire, France. · Centre urgence céphalées, hôpital Lariboisière, 2, rue Ambroise-Paré, 75010 Paris, France. · Inserm/UdA, U1107, Neuro-Dol Clermont-Ferrand, faculté de médecine, BP 38, 28, place Henri-Dunant, 63001 Clermont-Ferrand, France; Centre d'évaluation et de traitement de la douleur, hôpital de la Timone, boulevard Jean-Moulin, 264, rue Saint-Pierre, 13385 Marseille, France. Electronic address: · Pubmed 24594364
2011
  • Département d'Evaluation et Traitement de la Douleur, CHU de Nice, France, and INSERM 929 Clermont-Ferrand, France. · Pubmed 21457243
2018
  • Department of Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany. Electronic address: · NIHR-Wellcome Trust, King's Clinical Research Facility, King's College London, London, UK. · Pain Department and FHU InvoPain, CHU Nice-Université Côte d'Azur, Nice, France; INSERM U1107 Migraine and Trigeminal Pain, Auvergne University, Clermont-Ferrand, France. · Novartis, East Hanover, NJ, USA. · Novartis Pharma, Basel, Switzerland. · Department of Neurology, Leiden University Medical Centre, Leiden, Netherlands. · Pubmed 30360965
2010
Probable:    CHU de Clermont-Ferrand      
2016
  • Pôle neurosciences cliniques, département d'évaluation et traitement de la douleur, hôpital de Cimiez, CHU de Nice, 4, avenue Reine-Victoria, 06300 Nice, France; Inserm/UdA, U1107, neuro-dol, UFR odontologie, 2, rue de Braga, 63000 Clermont-Ferrand, France. Electronic address: · Cabinet de neuropyschiatrie, 12, rue Louis-Braille, 31250 Ramonville-Saint-Agne, France. · Pubmed 26708620
2011
  • Département d'Evaluation et Traitement de la Douleur, CHU de Nice, France, and INSERM 929 Clermont-Ferrand, France. · Pubmed 21457243
2018
  • Department of Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany. Electronic address: · NIHR-Wellcome Trust, King's Clinical Research Facility, King's College London, London, UK. · Pain Department and FHU InvoPain, CHU Nice-Université Côte d'Azur, Nice, France; INSERM U1107 Migraine and Trigeminal Pain, Auvergne University, Clermont-Ferrand, France. · Novartis, East Hanover, NJ, USA. · Novartis Pharma, Basel, Switzerland. · Department of Neurology, Leiden University Medical Centre, Leiden, Netherlands. · Pubmed 30360965
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 35 total) written by Michel Lantéri-Minet about Migraine Disorders:

  • Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study. 2018
  • ARISE: A Phase 3 randomized trial of erenumab for episodic migraine. 2018
  • My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed. 2018
  • Risk of medication overuse headache across classes of treatments for acute migraine. 2016
  • Epidemiology of migraine: French key descriptive data. 2016
  • Ergot Use and Overuse: A Pharmacoepidemiology Retrospective Cohort Study. 2016
  • Interictal burden attributable to episodic headache: findings from the Eurolight project. 2016
  • Triptans use and overuse: A pharmacoepidemiology study from the French health insurance system database covering 4.1 million people. 2015
  • Pain beliefs and perceptions inventory: a cross-sectional study in chronic and episodic migraine. 2015
  • [Management of chronic daily headache in migraine patients: medication overuse headache and chronic migraine. French guidelines (French Headache Society, French Private Neurologists Association, French Pain Society)]. 2014
Show List of Full Article Records
Google Searches

Learn more about Michel Lantéri-Minet using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous institutions in Nice
INSERM France
CHU de Clermont-Ferrand
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous institutions in Nice
2018
  • 1 Mayo Clinic, Scottsdale, AZ, USA. · 2 Danish Headache Center, Rigshospitalet Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · 3 Department of Neurology, Vanderbilt University School of Medicine and Nashville Neuroscience Group, Nashville, TN, USA. · 4 California Medical Clinic for Headache, Santa Monica, CA, USA. · 5 Pain Department and FHU InovPain, CHU Nice, France. · 6 Neurological Research Department, First Sechenov Moscow State Medical University and Research Center for Neuropsychiatry, Moscow, Russia. · 7 36026 Amgen Ltd , Cambridge, UK. · 8 7129 Amgen Inc. , Thousand Oaks, CA, USA. · Pubmed 29471679
  • European Headache Federation, Rome, Italy. · Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy. · Department of Neurology, Mayo Clinic, 5777 East Mayo Boulevard, Phoenix, AZ, 85054, USA. · Département d'Evaluation et Traitement de la Douleur CHU Nice, FHU InovPain, Université Côte Azur, Nice, France. · GfK EMER, Madrid, Spain. · IPSOS Switzerland (formerly GfK Health), Basel, Switzerland. · Department of Neurology and Headache Center, University of Duisburg-Essen, Duisburg, Germany. · European Migraine and Headache Alliance (EMHA), Brussels, Belgium. · Migraine Association of Ireland (MAI), Dublin, Ireland. · Danish Headache Center, Rigshospitalet Glostrup, Copenhagen, Denmark. · Migraine Action, Leicester, UK. · Novartis Pharma AG, Basel, Switzerland. · European Federation of Neurological Associations, Brussels, Belgium. · Migraine Again, Irvine, USA. · Pubmed 30482181
2016
  • Centre d'évaluation et de traitement de la douleur, Hôpital Timone, Pôle Neurosciences Cliniques, Hôpital de la Timone, Marseille, France. · INSERM/UdA, U1107, Neuro-Dol, Clermont-Ferrand, France. · Aix Marseille Université, CNRS 7289-Institut de Neurosciences Timone, Centre d'Evaluation et d'Information sur la Pharmacodépendance & Addictovigilance PACA-Corse, Service de Pharmacologie Médicale et Clinique, AP-HM, Marseille, France. · Direction Régionale du Service Médical de l'Assurance Maladie Provence-Alpes-Côte d'Azur et Corse (CNAMTS), Marseille, France. · Département d'Evaluation et Traitement de la Douleur, Pôle Neurosciences Cliniques du CHU de Nice, Hôpital Cimiez, Nice, France. · Pubmed 26995706
  • Headache Medical Center, Linz, Austria. · Department of Neurogeriatric Medicine and Remobilisation, Hospital of the Sisters of Charity, Linz, Austria. · Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway. · Norwegian Advisory Unit on Headache, St Olavs University Hospital, Trondheim, Norway. · Headache Science Centre, C Mondino National Neurological Institute, Pavia, Italy. · Department of Brain and Behavioural Sciences, University of Pavia, Pavia, Italy. · Department of Neurology, University of Duisberg-Essen, Essen, Germany. · Department of Neurology, Evangelical Hospital Unna, Unna, Germany. · Department of Neurology, Hospital Clinico Universitario, University of Valencia, Valencia, Spain. · Departement d'Evaluation et Traitement de la Douleur, Centre Hospitalo-Universitaire de Nice, Nice, France. · INSERM/UdA, U1107, Neuro-Dol, Clermont-Ferrand, France. · Lithuanian University of Health Sciences, Kaunas, Lithuania. · Asociacion Española de Pacientes con Cefalea (AEPAC), Valencia, Spain. · Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland. · Department of Population Health, Luxembourg Institute of Health, Strassen, Luxembourg. · Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway. · Division of Brain Sciences, Imperial College London, London, UK. · Pubmed 26879832
2014
  • Departement d'Evaluation et de Traitement de la Douleur, Hopital Cimiez, 4, avenue Reine-Victoria, 06000 Nice, France. · Pubmed 24400971
  • Département d'Evaluation et Traitement de la Douleur, Pôle Neurosciences Cliniques CHU de Nice, Hôpital de Cimiez, 4 avenue Reine Victoria, 06000, Nice, France, · Pubmed 24338699
2013
  • Département évaluation et traitement de la douleur, pôle neurosciences cliniques, hôpital de Cimiez, CHU de Nice, 4, avenue Reine-Victoria, 06001 Nice, France. · Pubmed 23602496
  • Département d'évaluation et de traitement de la douleur, hôpital Cimiez, 4, avenue Reine-Victoria, 06000 Nice, France. · Pubmed 23246266
2012
2011
  • Département d’Evaluation et Traitement de la Douleur Médecine Palliative, Pôle Neurosciences Cliniques, CHU de Nice-Hôpital Pasteur, 30 Avenue de la Voie Romaine, Nice cedex 1, France. · Pubmed 21464078
2010
  • Département d'Evaluation et Traitement de la Douleur, Pôle Neurosciences, Cliniques du Centre Hospitalo-Universitaire de Nice, Hôpital Pasteur, Nice, France. · Pubmed 20584227
  • Département d'Evaluation et Traitement de la Douleur, Pôle Neurosciences Cliniques, Hôpital Pasteur, 30 avenue de la Voie Romaine, 06002 Nice cedex, France. · Pubmed 20001575
2008
  • Département d'Evaluation et Traitement de la Douleur, Pôle Neurosciences Cliniques, Hôpital Pasteur, Nice, France. · Pubmed 18715326
  • Département d'évaluation et traitement de la douleur, pôle des neurosciences cliniques, CHU de Nice, hôpital Pasteur, 06002 Nice. · Pubmed 18437947
INSERM France
2016
  • Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, ON, Canada. · Redwood Outcomes, 302-1505 2nd Ave. West, Vancouver, BC, Canada. · Department of Medicine, St. Vincent's Hospital, The University of Melbourne, Melbourne, Australia. · Redwood Outcomes, 302-1505 2nd Ave. West, Vancouver, BC, Canada. · Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. · School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. · Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, ON, Canada. · Pfizer Ltd, New York, NY, USA. · Pain Department, CHU Nice, France - FHU InovPain, Université Nice Côte d'Azur, Nice, France. · INSERM U1107, Neuo-Dol, Trigeminal Pain and Migraine Université Auvergne, Clermont-Ferrand, France. · Geisel School of Medicine at Dartmouth, Hanover, NH, USA. · Pubmed 27882516
  • Pôle neurosciences cliniques, département d'évaluation et traitement de la douleur, hôpital de Cimiez, CHU de Nice, 4, avenue Reine-Victoria, 06300 Nice, France; Inserm/UdA, U1107, neuro-dol, UFR odontologie, 2, rue de Braga, 63000 Clermont-Ferrand, France. Electronic address: · Cabinet de neuropyschiatrie, 12, rue Louis-Braille, 31250 Ramonville-Saint-Agne, France. · Pubmed 26708620
  • Centre d'évaluation et de traitement de la douleur, Hôpital Timone, Pôle Neurosciences Cliniques, Hôpital de la Timone, Marseille, France. · INSERM/UdA, U1107, Neuro-Dol, Clermont-Ferrand, France. · Aix Marseille Université, CNRS 7289-Institut de Neurosciences Timone, Centre d'Evaluation et d'Information sur la Pharmacodépendance & Addictovigilance PACA-Corse, Service de Pharmacologie Médicale et Clinique, AP-HM, Marseille, France. · Direction Régionale du Service Médical de l'Assurance Maladie Provence-Alpes-Côte d'Azur et Corse (CNAMTS), Marseille, France. · Département d'Evaluation et Traitement de la Douleur, Pôle Neurosciences Cliniques du CHU de Nice, Hôpital Cimiez, Nice, France. · Pubmed 26995706
  • Headache Medical Center, Linz, Austria. · Department of Neurogeriatric Medicine and Remobilisation, Hospital of the Sisters of Charity, Linz, Austria. · Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway. · Norwegian Advisory Unit on Headache, St Olavs University Hospital, Trondheim, Norway. · Headache Science Centre, C Mondino National Neurological Institute, Pavia, Italy. · Department of Brain and Behavioural Sciences, University of Pavia, Pavia, Italy. · Department of Neurology, University of Duisberg-Essen, Essen, Germany. · Department of Neurology, Evangelical Hospital Unna, Unna, Germany. · Department of Neurology, Hospital Clinico Universitario, University of Valencia, Valencia, Spain. · Departement d'Evaluation et Traitement de la Douleur, Centre Hospitalo-Universitaire de Nice, Nice, France. · INSERM/UdA, U1107, Neuro-Dol, Clermont-Ferrand, France. · Lithuanian University of Health Sciences, Kaunas, Lithuania. · Asociacion Española de Pacientes con Cefalea (AEPAC), Valencia, Spain. · Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland. · Department of Population Health, Luxembourg Institute of Health, Strassen, Luxembourg. · Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway. · Division of Brain Sciences, Imperial College London, London, UK. · Pubmed 26879832
2015
  • Aix Marseille Université, CNRS 7289 - Institut de Neurosciences Timone, Centre d'Evaluation et d'Information sur la Pharmacodépendance & Addictovigilance PACA-Corse, Service de Pharmacologie Clinique et Pharmacovigilance, France. · Centre d'évaluation et de traitement de la douleur, hôpital Timone, Pôle Neurosciences Cliniques, Hôpital de la Timone, France INSERM/UdA, France. · Direction Régionale du Service Médical de l'Assurance Maladie Provence-Alpes-Côte d'Azur et Corse (CNAMTS), France. · INSERM/UdA, France Département d'Evaluation et traitement de la Douleur, Pôle Neurosciences Cliniques du CHU de Nice, Hôpital Cimiez, France. · Aix Marseille Université, CNRS 7289 - Institut de Neurosciences Timone, Centre d'Evaluation et d'Information sur la Pharmacodépendance & Addictovigilance PACA-Corse, Service de Pharmacologie Clinique et Pharmacovigilance, France · Pubmed 25667299
2014
  • Département d'évaluation et de traitement de la douleur, hôpital Cimiez, bâtiment Mossa, 4, avenue Reine-Victoria, 06000 Nice, France; Inserm/UdA, U1107, Neuro-Dol Clermont-Ferrand, faculté de médecine, BP 38, 28, place Henri-Dunant, 63001 Clermont-Ferrand, France. · Service de neurologie, hôpital de la Croix-Rousse, hospices Civils de Lyon, 103, grande rue de la Croix-Rousse, 69004 Lyon, France. · Cabinet privé, 73, boulevard de Cimiez, 06000 Nice, France. · Cabinet privé, 3, rue Henri Matisse, 91100 Corbeil Essonnes, France. · Cabinet privé, 90, rue Jean-Pierre-Timbaud, 75011 Paris, France. · Cabinet privé, 3, avenue Henri-Delecaux, 59130 Lambersart, France. · Unité de traitement de la douleur chronique, CHU de Bordeaux, 1, place Amélie-Raba-Léon, 33076 Bordeaux, France. · Service de neurologie, hôpital Rangueil, 1, avenue du Pr-Jean-Poulhès, TSA 50032, 31059 Toulouse cedex, France. · Centre d'évaluation et de traitement de la douleur, CHRU, avenue Georges-Clemenceau, 14033 Caen cedex 9, France. · Centre d'évaluation et de traitement de la douleur, hôpital Bellevue, CHU, pavillon 50, 42055 Saint-Étienne, France. · Cabinet privé, 13, place d'Aligre, 75012 Paris, France. · Cabinet privé, 1, chemin du Penthod, 69300 Caluire, France. · Centre urgence céphalées, hôpital Lariboisière, 2, rue Ambroise-Paré, 75010 Paris, France. · Inserm/UdA, U1107, Neuro-Dol Clermont-Ferrand, faculté de médecine, BP 38, 28, place Henri-Dunant, 63001 Clermont-Ferrand, France; Centre d'évaluation et de traitement de la douleur, hôpital de la Timone, boulevard Jean-Moulin, 264, rue Saint-Pierre, 13385 Marseille, France. Electronic address: · Pubmed 24594364
2011
  • Département d'Evaluation et Traitement de la Douleur, CHU de Nice, France, and INSERM 929 Clermont-Ferrand, France. · Pubmed 21457243
2018
  • Department of Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany. Electronic address: · NIHR-Wellcome Trust, King's Clinical Research Facility, King's College London, London, UK. · Pain Department and FHU InvoPain, CHU Nice-Université Côte d'Azur, Nice, France; INSERM U1107 Migraine and Trigeminal Pain, Auvergne University, Clermont-Ferrand, France. · Novartis, East Hanover, NJ, USA. · Novartis Pharma, Basel, Switzerland. · Department of Neurology, Leiden University Medical Centre, Leiden, Netherlands. · Pubmed 30360965
2010
CHU de Clermont-Ferrand
2016
  • Pôle neurosciences cliniques, département d'évaluation et traitement de la douleur, hôpital de Cimiez, CHU de Nice, 4, avenue Reine-Victoria, 06300 Nice, France; Inserm/UdA, U1107, neuro-dol, UFR odontologie, 2, rue de Braga, 63000 Clermont-Ferrand, France. Electronic address: · Cabinet de neuropyschiatrie, 12, rue Louis-Braille, 31250 Ramonville-Saint-Agne, France. · Pubmed 26708620
2011
  • Département d'Evaluation et Traitement de la Douleur, CHU de Nice, France, and INSERM 929 Clermont-Ferrand, France. · Pubmed 21457243
2018
  • Department of Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany. Electronic address: · NIHR-Wellcome Trust, King's Clinical Research Facility, King's College London, London, UK. · Pain Department and FHU InvoPain, CHU Nice-Université Côte d'Azur, Nice, France; INSERM U1107 Migraine and Trigeminal Pain, Auvergne University, Clermont-Ferrand, France. · Novartis, East Hanover, NJ, USA. · Novartis Pharma, Basel, Switzerland. · Department of Neurology, Leiden University Medical Centre, Leiden, Netherlands. · Pubmed 30360965
Universite Clermont Auvergne
2016
  • Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, ON, Canada. · Redwood Outcomes, 302-1505 2nd Ave. West, Vancouver, BC, Canada. · Department of Medicine, St. Vincent's Hospital, The University of Melbourne, Melbourne, Australia. · Redwood Outcomes, 302-1505 2nd Ave. West, Vancouver, BC, Canada. · Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. · School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. · Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, ON, Canada. · Pfizer Ltd, New York, NY, USA. · Pain Department, CHU Nice, France - FHU InovPain, Université Nice Côte d'Azur, Nice, France. · INSERM U1107, Neuo-Dol, Trigeminal Pain and Migraine Université Auvergne, Clermont-Ferrand, France. · Geisel School of Medicine at Dartmouth, Hanover, NH, USA. · Pubmed 27882516
2018
  • Department of Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany. Electronic address: · NIHR-Wellcome Trust, King's Clinical Research Facility, King's College London, London, UK. · Pain Department and FHU InvoPain, CHU Nice-Université Côte d'Azur, Nice, France; INSERM U1107 Migraine and Trigeminal Pain, Auvergne University, Clermont-Ferrand, France. · Novartis, East Hanover, NJ, USA. · Novartis Pharma, Basel, Switzerland. · Department of Neurology, Leiden University Medical Centre, Leiden, Netherlands. · Pubmed 30360965
Universite Cote d'Azur
2016
  • Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, ON, Canada. · Redwood Outcomes, 302-1505 2nd Ave. West, Vancouver, BC, Canada. · Department of Medicine, St. Vincent's Hospital, The University of Melbourne, Melbourne, Australia. · Redwood Outcomes, 302-1505 2nd Ave. West, Vancouver, BC, Canada. · Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. · School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. · Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, ON, Canada. · Pfizer Ltd, New York, NY, USA. · Pain Department, CHU Nice, France - FHU InovPain, Université Nice Côte d'Azur, Nice, France. · INSERM U1107, Neuo-Dol, Trigeminal Pain and Migraine Université Auvergne, Clermont-Ferrand, France. · Geisel School of Medicine at Dartmouth, Hanover, NH, USA. · Pubmed 27882516
2018
  • Department of Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany. Electronic address: · NIHR-Wellcome Trust, King's Clinical Research Facility, King's College London, London, UK. · Pain Department and FHU InvoPain, CHU Nice-Université Côte d'Azur, Nice, France; INSERM U1107 Migraine and Trigeminal Pain, Auvergne University, Clermont-Ferrand, France. · Novartis, East Hanover, NJ, USA. · Novartis Pharma, Basel, Switzerland. · Department of Neurology, Leiden University Medical Centre, Leiden, Netherlands. · Pubmed 30360965
9 Other Locations Show
Yearly article counts 030423343544
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.